Propranolol for the Treatment of Hemangiomatosis with Hepatic Lesions: Case Report with Great Response
Juniper Publishers- JOJ Dermatology & Cosmetics Abstract We present a case of a 2 months-old male nursling with neonatal hemangiomatosis with skin and hepatic, showing great response with systemic propranolol, with good acceptance, without side effects, after a 9 months follow-up. Keywords: Hemangiomatosis, Disseminated; Hemangioma/drug therapy; Liver Neoplasms/drug therapy; Propranolol/therapeutic use Abbreviations: IH: Infantile Hemangioma; ISSVA: International Society for the Study of Vascular Anomalies; NH: Neonatal Hemangiomatosis; BNH: Benign Neonatal Hemangiomatosis; VEGF: Vascular Growth Endothelial Factor; DNH: Diffuse Neonatal Hemangiomathosis; FGF: Fibroblast Growth Factor Introduction Vascular tumors are vasculature neoplasms that present endothelial cell proliferation. Infantile hemangioma (IH) is a proliferation of endothelial cells, that develop during the first 12-18 months of life, and then involute1. The lesions may be present at birth as a precursor l...